Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Treatment strategies for pediatric acute myeloid leukemia.

Absalon MJ, Smith FO.

Expert Opin Pharmacother. 2009 Jan;10(1):57-79. doi: 10.1517/14656560802627929 . Review.

PMID:
19236182
2.

Treatment of childhood acute myeloid leukemia.

ter Bals E, Kaspers GJ.

Expert Rev Anticancer Ther. 2005 Oct;5(5):917-29. Review.

PMID:
16221060
3.

Therapy of childhood acute myelogenous leukemias.

Vormoor J, Boos J, Stahnke K, Jürgens H, Ritter J, Creutzig U.

Ann Hematol. 1996 Jul;73(1):11-24. Review.

PMID:
8695718
4.

[Current therapeutic strategies in the management of acute myeloid leukemia].

Fiegl M, Hiddemann W, Braess J.

Med Klin (Munich). 2007 Apr 15;102(4):309-16. Review. German.

PMID:
17426934
5.

Acute myeloid leukemia and the position of autologous stem cell transplantation.

Breems DA, Löwenberg B.

Semin Hematol. 2007 Oct;44(4):259-66. Review.

PMID:
17961725
6.

Are new conditioning regimens for transplants in acute myelogenous leukemia better?

Aurer I, Gale RP.

Bone Marrow Transplant. 1991 Apr;7(4):255-61. Review.

PMID:
2070130
7.

Progress and controversies in the treatment of pediatric acute myelogenous leukemia.

Arceci RJ.

Curr Opin Hematol. 2002 Jul;9(4):353-60. Review.

PMID:
12042711
8.

Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies.

Creutzig U, Reinhardt D, Zimmermann M, Klingebiel T, Gadner H.

Blood. 2001 Jun 1;97(11):3671-2; author reply 3674-5. No abstract available.

9.

Therapy for older AML patients: the role of novel agents and allogeneic stem cell transplant.

Lancet JE, Giralt S.

J Natl Compr Canc Netw. 2008 Nov;6(10):1017-25. Review.

PMID:
19176199
10.

[Acute myeloid leukemia].

Tabuchi K.

Gan To Kagaku Ryoho. 2007 Feb;34(2):156-61. Japanese.

PMID:
17301520
11.

Acute myeloid leukemia.

Rubnitz JE, Gibson B, Smith FO.

Pediatr Clin North Am. 2008 Feb;55(1):21-51, ix. doi: 10.1016/j.pcl.2007.11.003. Review.

PMID:
18242314
12.

Acute myeloid leukemia.

Rubnitz JE, Gibson B, Smith FO.

Hematol Oncol Clin North Am. 2010 Feb;24(1):35-63. doi: 10.1016/j.hoc.2009.11.008. Review.

PMID:
20113895
13.

[Acute myeloid leukemia (AML)].

Büchner T.

Praxis (Bern 1994). 1999 Mar 4;88(10):421-30. Review. German.

PMID:
10199214
14.

Strategies in the treatment of acute myelogenous leukemia.

Vogler WR.

Leuk Res. 1992 Dec;16(12):1143-53. Review.

PMID:
1465023
15.

Targeted therapy in acute myeloid leukaemia: current status and future directions.

Stapnes C, Gjertsen BT, Reikvam H, Bruserud Ø.

Expert Opin Investig Drugs. 2009 Apr;18(4):433-55. doi: 10.1517/14728220902787628 . Review.

PMID:
19335274
16.

Intensive chemotherapy and bone marrow transplantation for children with acute myeloid leukemia.

Horan J, Korones D.

Blood. 2001 Jun 1;97(11):3672-3; author reply 3674-5. No abstract available.

17.

Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML).

Sjøholt G, Bedringaas SL, Døskeland AP, Gjertsen BT.

Curr Pharm Biotechnol. 2006 Jun;7(3):159-70. Review.

PMID:
16789901
18.

Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.

Tsukimoto I, Tawa A, Horibe K, Tabuchi K, Kigasawa H, Tsuchida M, Yabe H, Nakayama H, Kudo K, Kobayashi R, Hamamoto K, Imaizumi M, Morimoto A, Tsuchiya S, Hanada R.

J Clin Oncol. 2009 Aug 20;27(24):4007-13. doi: 10.1200/JCO.2008.18.7948. Epub 2009 Jul 20.

PMID:
19620491
19.

Inhibition of raf kinase in the treatment of acute myeloid leukemia.

Crump M.

Curr Pharm Des. 2002;8(25):2243-8. Review.

PMID:
12369851
20.

[Risk-adapted therapy of acute myeloid leukemia].

Hiddemann W, Spiekermann K, Braess J, Feuring-Buske M, Buske C, Büchner T.

Internist (Berl). 2006 Jun;47 Suppl 1:S33-9. Review. German.

PMID:
16773364

Supplemental Content

Support Center